Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Research Communications in Chemical Pathology and Pharmacology|June 1, 1980
Metabolism of methotrexate in man after high and conventional dosesK K Chan, M S Nayar, J L Cohen, et al.
Cancer|June 15, 1984
Hepatocellular carcinoma. Diagnostic and prognostic features in North American patientsR T Chlebowski, M Tong, J Weissman, et al.
Cancer|February 1, 1987
Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experienceR T Chlebowski, L Bulcavage, M Grosvenor, et al.
Cancer Research|November 1, 1981
Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group ProjectR T Chlebowski, J M Weiner, J Luce, et al.
Controlled Clinical Trials|December 1, 1989
Unpublished Data Summaries and the design and conduct of clinical trials. The Nutrition Adjuvant Study experience and commentaryR T Chlebowski, G L Blackburn, D W Nixon, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|November 1, 1993
Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trialR T Chlebowski, G Beall, M Grosvenor, et al.
Breast Cancer Research and Treatment|October 1, 1987
A breast cancer Nutrition Adjuvant Study (NAS): protocol design and initial patient adherenceR T Chlebowski, D W Nixon, G L Blackburn, et al.
Breast Cancer Research and Treatment|November 26, 2015
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicityR T Chlebowski, R Haque, H Hedlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert PanelB E Hillner, J N Ingle, J R Berenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition StudyR T Chlebowski, G L Blackburn, I M Buzzard, et al.
Pageof 8